Emoţie… emoţie… pe ecranul ecografului se vede un punct. Un punct care bate. Încă o mişcare şi…da! Este inima Anastasiei, o nouă viaţă ce porneşte la drum. O viaţă ce va schimba vieţi.
Anastasia s-a născut în anul 2011 în Bucureşti. A adus bucurie în familie şi multe lacrimi de fericire. Câţiva ani mai târziu Anastasia a adus şi lacrimi de neputinţă. Fără să depindă ceva de ea, fără că părinţii să poată face ceva înainte, Anastasia a aflat că suferă de tetrapareză cerebrală infantilă formă spastică distonică bilaterală, o boală cauzată de lipsa oxigenării creierului pentru un interval de timp, la naştere.
Toamna lui 2014
În casa Anastasiei este acum linişte, micuţa doarme iar părinţii ei sunt în bucătărie. Telefonul le aduce o veste neaşteptată şi în acelaşi timp greu de înţeles. Anastasia ar putea face parte din echipa celor care creează medicină viitorului. Anastasia poate fi un deschizător de drumuri, un copil care poate scrie istorie. Celulele stem recoltate de mama la naşterea ei, ar putea să fie puse la treabă şi să ajute în tratamentul de care suferă acum micuţa.
Ai putea să refuzi o asemenea ştire? Ai putea oare să spui că nu vrei să încerci? Mama Anastasiei a spus DA!
…şi aventura începe
În toamna anului 2014, Anastasia merge pentru prima dată în Polonia, la spitalul Spitalul Universitar de Copii din Cracovia, ajutată de către Biogenis, banca de celule stem unde are stocate acum şi celulele stem. Fetiţa primeşte prima infuzie cu celule stem şi pleacă acasă chiar a doua zi după intervenţie.
…
După doar două săptămâni, părinţii Anastasiei observă şi primele rezultate pozitive. Pentru prima dată, Anastasia spune mama, pentru că mai apoi fetiţa să poată mânca, să poată înghiţi, să-şi îmbunătăţească motricitatea. Mai are un drum lung de parcus însă speranţa a prins aripi şi merge mai departe. Anul acesta Anastasia a fost din nou în Polonia şi a mai făcut o intervenţie. Cu siguranţă vor urmă şi altele. Cu toţii ne dorim să vedem rezultatele cât mai repede, încurajaţi fiind şi de sutele de oameni care fac un tratament cu celule stem chiar acum, în grupul de bănci de celule stem din care face parte şi Biogenis, banca ce a stocat pentru prima dată celulele stem ale Anastasiei. Peste 3000 de pacienţi sunt trataţi acum în acest grup, încercându-se o rezolvare pentru boli precum epilepsie, Alzheimer, autism, scleroză laterală, paralizie cerebrală, scleroză multiplă, encefalopatie, orbire…
Cand viata castiga, nimic nu te mai poate opri. Cand viata castiga, te bucuri ca ai facut ce trebuia, ii inveti si pe altii si aduci bucurie la randul tau.
Poţi vedea poveştile Biogenis pe www.biogenis.ro/candviatacastiga
Biogenis, mai mult decât o bancă de celule stem.
No. | Cell source | Type of source | Indication | Area of medicine | Year | Type of therapy | Country | Age |
---|---|---|---|---|---|---|---|---|
1 | cord blood | autologous | autism | neurology | 2018 | experimental therapy | USA | 8 |
2 | cord blood | autologous | autism | neurology | 2018 | experimental therapy | USA | 6 |
3 | cord blood | autologous | cerebral palsy | neurology | 2018 | experimental therapy | USA | 1 |
4 | cord blood | allogeneic - sibling | sickle cell anemia | hematology | 2018 | standard therapy | Turkey | 10 |
5 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 10 |
6 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 5 |
7 | cord blood | allogeneic - sibling | autism | neurology | 2018 | experimental therapy | Poland | 3 |
8 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 4 |
9 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 4 |
10 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 9 |
11 | cord blood | autologous | aplastic anaemia | hematology | 2018 | standard therapy | Poland | 3 |
12 | cord blood | allogeneic - sibling | chronic granulomatous disease | hematology | 2017 | standard therapy | Turkey | 3 |
13 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 4 |
14 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 4 |
15 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 5 |
16 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 7 |
17 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 6 |
18 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
19 | cord blood | allogeneic - sibling | relapse of acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 7 |
20 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 4 |
21 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10 |
22 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
23 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
24 | cord blood | allogeneic - sibling | talassemia major | hematology | 2017 | standard therapy | Turkey | 4 |
25 | cord blood | allogeneic - sibling | talassemia major | hematology | 2017 | standard therapy | Turkey | 4 |
26 | cord blood | allogeneic - sibling | CD40 ligand deficiency | hematology | 2017 | standard therapy | Turkey | 9 |
27 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Hungary | 7 |
28 | cord blood | autologous | autism | neurology | 2016 | experimental therapy | Poland | 6 |
29 | cord blood | allogeneic - unrelated | acute myeloid leukemia | hematology | 2016 | standard therapy | Jordan | 6 |
30 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2015 | standard therapy | Poland | 4 |
31 | cord blood | autologous | acute myeloid leukemia | hematology | 2014 | standard therapy | Spain | 6 |
32 | cord blood | autologous | cerebral palsy | neurology | 2014 | experimental therapy | Spain | 4 |
33 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2014 | standard therapy | Turkey | 7 |
34 | cord blood | allogeneic - sibling | X - linked lymphoproliferative syndrome | hematology | 2013 | standard therapy | Poland | below 1 |
35 | cord blood | allogeneic - sibling | beta-talassemia, agranulocytosis | hematology | 2013 | standard therapy | Turkey | 8 |
36 | cord blood | allogeneic - sibling | acute myeloid leukemia | hematology | 2013 | standard therapy | Poland | 3 |
37 | cord blood | allogeneic - sibling | aplastic anaemia | hematology | 2013 | standard therapy | Poland | 3 |
38 | cord blood | autologous | cerebral palsy | neurology | 2012 | experimental therapy | USA | 3 |
39 | cord blood | allogeneic - sibling | T-acute lymphoblastic leukemia | hematology | 2012 | standard therapy | Turkey | 5 |
40 | cord blood | allogeneic - sibling | talassemia major, acute lymphoblastic leukemia | hematology | 2012 | standard therapy | Turkey | 3 |
41 | cord blood | allogeneic - sibling | anaemia, talassemia major | hematology | 2012 | standard therapy | Turkey | 6 |
42 | cord blood | allogeneic - sibling | severe aplastic anaemia | hematology | 2012 | standard therapy | Hungary | 3 |
43 | cord blood | autologous | cerebral palsy | neurology | 2011 | experimental therapy | USA | 6 |
44 | cord blood | allogeneic - sibling | chronic granulomatous disease | hematology | 2011 | standard therapy | Poland | 7 |
45 | cord blood | allogeneic - sibling | histiocytosis | hematology | 2011 | standard therapy | Poland | 2 |
46 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2011 | standard therapy | Poland | 5 |
47 | cord blood | allogeneic - sibling | acute myeloid leukemia | hematology | 2011 | standard therapy | Hungary | 2 |
48 | cord blood | allogeneic - sibling | Fanconi anemia | hematology | 2011 | standard therapy | Poland | 12 |
49 | cord blood | autologous | cerebral palsy | neurology | 2010 | experimental therapy | USA | 6 |
50 | cord blood | autologous | cerebral palsy | neurology | 2010 | experimental therapy | USA | 1 |
51 | cord blood | autologous | cerebral palsy | neurology | 2010 | experimental therapy | USA | 1 |
52 | cord blood | allogeneic - sibling | pre -B acute lymphoblastic leukemia | hematology | 2010 | standard therapy | Hungary | 1 |
53 | cord blood | autologous | cerebral palsy | neurology | 2009 | experimental therapy | USA | 2 |
54 | cord blood | autologous | cerebral palsy | neurology | 2009 | experimental therapy | USA | 2 |
55 | cord blood | allogeneic - sibling | myelodysplastic syndrome | hematology | 2009 | standard therapy | Poland | 5 |
56 | cord blood | autologous | cerebral ischemia | neurology | 2008 | experimental therapy | Poland | 1 |
57 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2008 | standard therapy | Poland | 5 |
58 | cord blood | allogeneic - sibling | SCID, severe combined immunodeficiency | hematology | 2007 | standard therapy | Portugal | 1 |
59 | cord blood | allogeneic - sibling | neuroblastoma | hematology | 2007 | standard therapy | Poland | 8 |
60 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
61 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
62 | cord tissue (Wharton's jelly) | allo-related | coxarthrosis | orthopedics | 2019 | experimental therapy | Poland | 57 |
63 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 35 |
64 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 23 |
65 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 26 |
66 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2019 | experimental therapy | Poland | 21 |
67 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 33 |
68 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 72 |
69 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2019 | experimental therapy | Poland | 35 |
70 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 68 |
71 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 43 |
72 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2019 | experimental therapy | Poland | 38 |
73 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2019 | experimental therapy | Poland | 19 |
74 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2019 | experimental therapy | Poland | 26 |
75 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 60 |
76 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 65 |
77 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 58 |
78 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 54 |
79 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 5 |
80 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2019 | experimental therapy | Poland | 39 |
81 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 11 |
82 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 3 |
83 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida, epilepsy | neurology | 2019 | experimental therapy | Poland | 2 |
84 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 3 |
85 | cord tissue (Wharton's jelly) | allo-unrelated | microcephalia, cerebellar syndrome, delayed psychomotor development | neurology | 2019 | experimental therapy | Poland | 7 |
86 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia, encephalopathy | neurology | 2019 | experimental therapy | Poland | 8 |
87 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development, Chiari malformation | neurology | 2019 | experimental therapy | Poland | 4 |
88 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy, epilepsy | neurology | 2019 | experimental therapy | Poland | 17 |
89 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 0 |
90 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 9 |
91 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 6 |
92 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 55 |
93 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | no data |
94 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | no data |
95 | cord tissue (Wharton's jelly) | allo-related | autism | neurology | 2018 | experimental therapy | Poland | 4 |
96 | cord tissue (Wharton's jelly) | allo-unrelated | autism, delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 6 |
97 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 52 |
98 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 42 |
99 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 36 |
100 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 60 |
101 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurologia | 2018 | experimental therapy | Poland | 9 |
102 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurologia | 2018 | experimental therapy | Poland | 2 |
103 | cord tissue (Wharton's jelly) | allo-unrelated | cartilage damage | ortopedia | 2018 | experimental therapy | Poland | 56 |
104 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system - syndrom Pierre-Robin | neurology | 2018 | experimental therapy | Poland | 2 |
105 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 4 |
106 | cord tissue (Wharton's jelly) | allo-unrelated | hydrocephalus, myelomeningocele | neurology | 2018 | experimental therapy | Poland | 2 |
107 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2018 | experimental therapy | Poland | 64 |
108 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
109 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 54 |
110 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
111 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development, epilepsia | neurology | 2018 | experimental therapy | Poland | 4 |
112 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
113 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
114 | cord tissue (Wharton's jelly) | allo-unrelated | genetic syndrome - deletion of part of chromosome 3 | neurology | 2018 | experimental therapy | Poland | 8 |
115 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia, autism | neurology | 2018 | experimental therapy | Poland | 8 |
116 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
117 | cord tissue (Wharton's jelly) | allo-related | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 10 |
118 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
119 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 44 |
120 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 42 |
121 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 38 |
122 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 10 |
123 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 15 |
124 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2018 | experimental therapy | Poland | 5 |
125 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 54 |
126 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 56 |
127 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 53 |
128 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 39 |
129 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 46 |
130 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 33 |
131 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 12 |
132 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
133 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 34 |
134 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
135 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 3 |
136 | cord tissue (Wharton's jelly) | allo-unrelated | Leber's hereditary optic neuropathy | ophthalmology | 2018 | experimental therapy | Poland | 18 |
137 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2018 | experimental therapy | Poland | 18 |
138 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2018 | experimental therapy | Poland | 15 |
139 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 34 |
140 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2018 | experimental therapy | Poland | 4 |
141 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
142 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia, agenesis corporis callosi | neurology | 2018 | experimental therapy | Poland | 2 |
143 | cord tissue (Wharton's jelly) | allo-unrelated | congenital myasthenia | neurology | 2018 | experimental therapy | Poland | 3 |
144 | cord tissue (Wharton's jelly) | allo-unrelated | congenital myasthenia | neurology | 2018 | experimental therapy | Poland | 6 |
145 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2018 | experimental therapy | Poland | 7 |
146 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2018 | experimental therapy | Poland | 5 |
147 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 44 |
148 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 16 |
149 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system- Pitt Hopkins syndrome | neurology | 2018 | experimental therapy | Poland | 10 |
150 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 1 |
151 | cord tissue (Wharton's jelly) | allo-unrelated | myelomeningocele | neurology | 2018 | experimental therapy | Poland | 1 |
152 | cord tissue (Wharton's jelly) | allo-unrelated | multiple system atrophy | neurology | 2018 | experimental therapy | Poland | 61 |
153 | cord tissue (Wharton's jelly) | allo-unrelated | Friedreich's ataxia | neurology | 2018 | experimental therapy | Poland | 22 |
154 | cord tissue (Wharton's jelly) | allo-unrelated | neuropathy | neurology | 2018 | experimental therapy | Poland | 47 |
155 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 7 |
156 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 13 |
157 | cord tissue (Wharton's jelly) | allo-unrelated | progressive supranuclear atrophy | neurology | 2018 | experimental therapy | Poland | 62 |
158 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
159 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
160 | cord tissue (Wharton's jelly) | allo-unrelated | multiple system atrophy | neurology | 2018 | experimental therapy | Poland | 47 |
161 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 62 |
162 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 49 |
163 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 2 |
164 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
165 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
166 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 7 |
167 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 49 |
168 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
169 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 8 |
170 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 2 |
171 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 1 |
172 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
173 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
174 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 42 |
175 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 30 |
176 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 73 |
177 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 66 |
178 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
179 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 30 |
180 | cord tissue (Wharton's jelly) | allo-unrelated | paralysis | neurology | 2018 | experimental therapy | Poland | 9 |
181 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 2 |
182 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
183 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 50 |
184 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 22 |
185 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 38 |
186 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis | orthopedics | 2018 | experimental therapy | Poland | 32 |
187 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
188 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
189 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
190 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
191 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 9 |
192 | cord tissue (Wharton's jelly) | allo-related | autism, congenital cytomegaly | neurology | 2018 | experimental therapy | Poland | 6 |
193 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
194 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 9 |
195 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 2 |
196 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 48 |
197 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 41 |
198 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 40 |
199 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 7 |
200 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 78 |
201 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 60 |
202 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 3 |
203 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 61 |
204 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
205 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome, delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 3 |
206 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 1 |
207 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 13 |
208 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
209 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 15 |
210 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 2 |
211 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 1 |
212 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 4 |
213 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 42 |
214 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
215 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 3 |
216 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 43 |
217 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 62 |
218 | cord tissue (Wharton's jelly) | allo-unrelated | bilateral edema of the optic nerves | ophthalmology | 2018 | experimental therapy | Poland | 12 |
219 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 4 |
220 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
221 | cord tissue (Wharton's jelly) | allo-unrelated | Phelan-McDermid Syndrome | neurology | 2018 | experimental therapy | Poland | 17 |
222 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2018 | experimental therapy | Poland | 24 |
223 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 8 |
224 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | below 1 |
225 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
226 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 1 |
227 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 12 |
228 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 70 |
229 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 18 |
230 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 51 |
231 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, encephalopathy | neurology | 2018 | experimental therapy | Poland | 1 |
232 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 8 |
233 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 78 |
234 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 68 |
235 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 7 |
236 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 4 |
237 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 26 |
238 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia | neurology | 2018 | experimental therapy | Poland | 7 |
239 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
240 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 3 |
241 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 1 |
242 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 64 |
243 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 7 |
244 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2018 | experimental therapy | Poland | 82 |
245 | cord tissue (Wharton's jelly) | allo-unrelated | visual pathway dysfunction | ophthalmology | 2018 | experimental therapy | Poland | 48 |
246 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 21 |
247 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 71 |
248 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 69 |
249 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 22 |
250 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
251 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
252 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 11 |
253 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 58 |
254 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 56 |
255 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2018 | experimental therapy | Poland | 11 |
256 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | neurology | 2018 | experimental therapy | Poland | 12 |
257 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 64 |
258 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
259 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia | neurology | 2018 | experimental therapy | Poland | 9 |
260 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy, developmental delay | neurology | 2018 | experimental therapy | Poland | 8 |
261 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 7 |
262 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 7 |
263 | cord tissue (Wharton's jelly) | allo-unrelated | degeneration of the cartilage of the knee joint | orthopedics | 2018 | experimental therapy | Poland | 57 |
264 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 1 |
265 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 66 |
266 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 70 |
267 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
268 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
269 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 1 |
270 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 61 |
271 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 37 |
272 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 50 |
273 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 23 |
274 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 69 |
275 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 18 |
276 | cord tissue (Wharton's jelly) | allo-unrelated | brain disorder, unspecified | neurology | 2018 | experimental therapy | Poland | 10 |
277 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 85 |
278 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 2 |
279 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
280 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
281 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 1 |
282 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 38 |
283 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
284 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
285 | cord tissue (Wharton's jelly) | allo-unrelated | Wolf-Hirschhorn syndrome | neurology | 2018 | experimental therapy | Poland | 1 |
286 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy, epilepsy | neurology | 2018 | experimental therapy | Poland | 21 |
287 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
288 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | below 1 |
289 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 6 |
290 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 38 |
291 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 64 |
292 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 29 |
293 | cord tissue (Wharton's jelly) | allo-unrelated | state after encephalitis, epilepsy | neurology | 2018 | experimental therapy | Poland | 44 |
294 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 42 |
295 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 44 |
296 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 47 |
297 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 27 |
298 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
299 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
300 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
301 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
302 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
303 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 48 |
304 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 55 |
305 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 16 |
306 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
307 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
308 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
309 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 5 |
310 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 4 |
311 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
312 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia | neurology | 2018 | experimental therapy | Poland | 2 |
313 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 48 |
314 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
315 | cord tissue (Wharton's jelly) | allo-unrelated | microcephalia | neurology | 2018 | experimental therapy | Poland | 12 |
316 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 67 |
317 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 5 |
318 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 55 |
319 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 34 |
320 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
321 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
322 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 11 |
323 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
324 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 66 |
325 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
326 | cord tissue (Wharton's jelly) | allo-unrelated | lack of expected normal physical development, unspecified | neurology | 2018 | experimental therapy | Poland | 10 |
327 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
328 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
329 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
330 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
331 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
332 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
333 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 62 |
334 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 28 |
335 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
336 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 16 |
337 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development, atrophy of the optic nerves | neurology | 2018 | experimental therapy | Poland | 2 |
338 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 11 |
339 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
340 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 13 |
341 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
342 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 25 |
343 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 64 |
344 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 67 |
345 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 47 |
346 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 39 |
347 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
348 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 63 |
349 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 64 |
350 | cord tissue (Wharton's jelly) | allo-unrelated | arthrogryposis multiplex congenita, epilepsia | neurology | 2018 | experimental therapy | Poland | 6 |
351 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
352 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 49 |
353 | cord tissue (Wharton's jelly) | allo-unrelated | other reduction deformities of brain, schizencephaly | neurology | 2018 | experimental therapy | Poland | 5 |
354 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
355 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 53 |
356 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 44 |
357 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 38 |
358 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 62 |
359 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 67 |
360 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 6 |
361 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
362 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 13 |
363 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy, cerebral palsy | neurology | 2018 | experimental therapy | Poland | 22 |
364 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 4 |
365 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 75 |
366 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2018 | experimental therapy | Poland | no data |
367 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 66 |
368 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 47 |
369 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 64 |
370 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 10 |
371 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 1 |
372 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 9 |
373 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 70 |
374 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 40 |
375 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 31 |
376 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 60 |
377 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65 |
378 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65 |
379 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 22 |
380 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica DMD | neurology | 2018 | experimental therapy | Poland | 8 |
381 | cord tissue (Wharton's jelly) | allo-unrelated | holoprosencephalia | neurology | 2018 | experimental therapy | Poland | 12 |
382 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 25 |
383 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 80 |
384 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 35 |
385 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 54 |
386 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 76 |
387 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 9 |
388 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 2 |
389 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 80 |
390 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia myotonica | neurology | 2018 | experimental therapy | Poland | 27 |
391 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
392 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 75 |
393 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 34 |
394 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 20 |
395 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 61 |
396 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 28 |
397 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 45 |
398 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 57 |
399 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 57 |
400 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 83 |
401 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 35 |
402 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 41 |
403 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 67 |
404 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2018 | experimental therapy | Poland | 7 |
405 | cord tissue (Wharton's jelly) | allo-unrelated | damage to the intercondylar fissure of the right knee | orthopedics | 2018 | experimental therapy | Poland | 40 |
406 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 54 |
407 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2018 | experimental therapy | Poland | 54 |
408 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
409 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
410 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
411 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 9 |
412 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2018 | experimental therapy | Poland | 7 |
413 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 40 |
414 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 21 |
415 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 62 |
416 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
417 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
418 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 28 |
419 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 52 |
420 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 47 |
421 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 46 |
422 | cord tissue (Wharton's jelly) | allo-unrelated | Friedreich's ataxia | neurology | 2018 | experimental therapy | Poland | 31 |
423 | cord tissue (Wharton's jelly) | allo-unrelated | Friedreich's ataxia | neurology | 2018 | experimental therapy | Poland | 27 |
424 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 70 |
425 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 9 |
426 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 55 |
427 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2018 | experimental therapy | Poland | 20 |
428 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 34 |
429 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 44 |
430 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 30 |
431 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2018 | experimental therapy | Poland | 46 |
432 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 20 |
433 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65 |
434 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 30 |
435 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 38 |
436 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 46 |
437 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2018 | experimental therapy | Poland | 14 |
438 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 38 |
439 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 51 |
440 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 50 |
441 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 59 |
442 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 47 |
443 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 66 |
444 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 52 |
445 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 33 |
446 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 3 |
447 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 27 |
448 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 34 |
449 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 36 |
450 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 55 |
451 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 39 |
452 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 46 |
453 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 32 |
454 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 41 |
455 | cord tissue (Wharton's jelly) | allo-unrelated | degeneration of the cartilage of the knee joint | orthopedics | 2018 | experimental therapy | Poland | 34 |
456 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 1 |
457 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 67 |
458 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 66 |
459 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 28 |
460 | cord tissue (Wharton's jelly) | allo-unrelated | myopathy | neurology | 2018 | experimental therapy | Poland | 57 |
461 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 2 |
462 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 52 |
463 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 44 |
464 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 48 |
465 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 59 |
466 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 3 |
467 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 44 |
468 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 16 |
469 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 61 |
470 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 36 |
471 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 25 |
472 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 31 |
473 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 68 |
474 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 71 |
475 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 57 |
476 | cord tissue (Wharton's jelly) | allo-unrelated | anterior ischemic optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 67 |
477 | cord tissue (Wharton's jelly) | allo-unrelated | moyamoya disease | neurology | 2017 | experimental therapy | Poland | 17 |
478 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | below 1 |
479 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 7 |
480 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
481 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
482 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 48 |
483 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 14 |
484 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 15 |
485 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 8 |
486 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 48 |
487 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 66 |
488 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 7 |
489 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1 |
490 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 7 |
491 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
492 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 45 |
493 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 36 |
494 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 33 |
495 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 7 |
496 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8 |
497 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2017 | experimental therapy | Poland | 2 |
498 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54 |
499 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 6 |
500 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
501 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 46 |
502 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 59 |
503 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43 |
504 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 37 |
505 | cord tissue (Wharton's jelly) | allo-unrelated | cartilage damage | orthopedics | 2017 | experimental therapy | Poland | 46 |
506 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 64 |
507 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 69 |
508 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 5 |
509 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
510 | cord tissue (Wharton's jelly) | allo-unrelated | autism, encephalopathy | neurology | 2017 | experimental therapy | Poland | 7 |
511 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2017 | experimental therapy | Poland | 2 |
512 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 52 |
513 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
514 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 17 |
515 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10 |
516 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65 |
517 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61 |
518 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78 |
519 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 29 |
520 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 24 |
521 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
522 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 10 |
523 | cord tissue (Wharton's jelly) | allo-unrelated | congenital malformations of the nervous system, unspecified | neurology | 2017 | experimental therapy | Poland | 8 |
524 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 60 |
525 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 35 |
526 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 52 |
527 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 8 |
528 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1 |
529 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 28 |
530 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 60 |
531 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2017 | experimental therapy | Poland | 2 |
532 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 85 |
533 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 66 |
534 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 12 |
535 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8 |
536 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 14 |
537 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 38 |
538 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 24 |
539 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 11 |
540 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
541 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury, tetraparesis | orthopedics | 2017 | experimental therapy | Poland | 42 |
542 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 5 |
543 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica, epilepsia | neurology | 2017 | experimental therapy | Poland | 2 |
544 | cord tissue (Wharton's jelly) | allo-unrelated | hypoxia-ischemic encephalopathy | neurology | 2017 | experimental therapy | Poland | 1 |
545 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 65 |
546 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61 |
547 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 12 |
548 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 3 |
549 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 37 |
550 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78 |
551 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 44 |
552 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 22 |
553 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1 |
554 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
555 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 32 |
556 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2017 | experimental therapy | Poland | 1 |
557 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10 |
558 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
559 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 7 |
560 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 18 |
561 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development, epilepsia | neurology | 2017 | experimental therapy | Poland | 11 |
562 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 9 |
563 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 22 |
564 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43 |
565 | cord tissue (Wharton's jelly) | allo-unrelated | condition after myelitis | neurology | 2017 | experimental therapy | Poland | 34 |
566 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 33 |
567 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78 |
568 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 30 |
569 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 77 |
570 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54 |
571 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 2 |
572 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65 |
573 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 47 |
574 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
575 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
576 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 27 |
577 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
578 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
579 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
580 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | no data |
581 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 53 |
582 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 55 |
583 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
584 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 13 |
585 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2017 | experimental therapy | Poland | 3 |
586 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15 |
587 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
588 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 9 |
589 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 8 |
590 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis | orthopedics | 2017 | experimental therapy | Poland | 27 |
591 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | no data |
592 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 16 |
593 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2017 | experimental therapy | Poland | 35 |
594 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2017 | experimental therapy | Poland | 7 |
595 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 53 |
596 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46 |
597 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59 |
598 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 57 |
599 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 62 |
600 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 63 |
601 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 4 |
602 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
603 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
604 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 58 |
605 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 25 |
606 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 38 |
607 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56 |
608 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 10 |
609 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 4 |
610 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 2 |
611 | cord tissue (Wharton's jelly) | allo-unrelated | global developmental delay | neurology | 2017 | experimental therapy | Poland | 7 |
612 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 60 |
613 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 49 |
614 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59 |
615 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 68 |
616 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
617 | cord tissue (Wharton's jelly) | allo-unrelated | myopathy of congenital fiber type disproportion, damage to the central nervous system | neurology | 2017 | experimental therapy | Poland | 2 |
618 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia, autism | neurology | 2017 | experimental therapy | Poland | 6 |
619 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
620 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 6 |
621 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 31 |
622 | cord tissue (Wharton's jelly) | allo-unrelated | Devic’s disease | neurology | 2017 | experimental therapy | Poland | 45 |
623 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
624 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
625 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
626 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
627 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
628 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 7 |
629 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 13 |
630 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 10 |
631 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 18 |
632 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 26 |
633 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 12 |
634 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51 |
635 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 5 |
636 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15 |
637 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8 |
638 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2017 | experimental therapy | Poland | 5 |
639 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 65 |
640 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 70 |
641 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51 |
642 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 64 |
643 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 74 |
644 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 43 |
645 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
646 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /BMD | neurology | 2017 | experimental therapy | Poland | 23 |
647 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 76 |
648 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 63 |
649 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 3 |
650 | cord tissue (Wharton's jelly) | allo-unrelated | arthrogryposis multiplex congenita | neurology | 2017 | experimental therapy | Poland | 3 |
651 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 7 |
652 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 2 |
653 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 3 |
654 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8 |
655 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 4 |
656 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 39 |
657 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 30 |
658 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 2 |
659 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 42 |
660 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 33 |
661 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 3 |
662 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 4 |
663 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 56 |
664 | cord tissue (Wharton's jelly) | allo-unrelated | global developmental delay | neurology | 2017 | experimental therapy | Poland | 4 |
665 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 41 |
666 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54 |
667 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 46 |
668 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 32 |
669 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 6 |
670 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 13 |
671 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 7 |
672 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy, cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1 |
673 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 6 |
674 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 1 |
675 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 35 |
676 | cord tissue (Wharton's jelly) | allo-unrelated | condition after encephalitis | neurology | 2017 | experimental therapy | Poland | 19 |
677 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 49 |
678 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46 |
679 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 6 |
680 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 6 |
681 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 4 |
682 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
683 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 60 |
684 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 62 |
685 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 48 |
686 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 31 |
687 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 45 |
688 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51 |
689 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 24 |
690 | cord tissue (Wharton's jelly) | allo-unrelated | Krabbe disease | neurology | 2017 | experimental therapy | Poland | 6 |
691 | cord tissue (Wharton's jelly) | allo-unrelated | hypoxia-ischemic encephalopathy | neurology | 2017 | experimental therapy | Poland | 1 |
692 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 5 |
693 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
694 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
695 | cord tissue (Wharton's jelly) | allo-related | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 12 |
696 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
697 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 33 |
698 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 10 |
699 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 31 |
700 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 31 |
701 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 35 |
702 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 63 |
703 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 36 |
704 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 77 |
705 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
706 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 35 |
707 | cord tissue (Wharton's jelly) | allo-unrelated | ischemia within the optic nerve | ophthalmology | 2017 | experimental therapy | Poland | 37 |
708 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 66 |
709 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 11 |
710 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 13 |
711 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 52 |
712 | cord tissue (Wharton's jelly) | allo-unrelated | syndrom IFAP | hematology | 2017 | experimental therapy | Poland | 3 |
713 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 6 |
714 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 3 |
715 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 7 |
716 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 6 |
717 | cord tissue (Wharton's jelly) | allo-unrelated | hydrocephalus, neonatal cerebral leukomalacia | neurology | 2017 | experimental therapy | Poland | 2 |
718 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 31 |
719 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 34 |
720 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 45 |
721 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 27 |
722 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 52 |
723 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 31 |
724 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 37 |
725 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 24 |
726 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 69 |
727 | cord tissue (Wharton's jelly) | allo-unrelated | no bone adhesion | orthopedics | 2017 | experimental therapy | Poland | 17 |
728 | cord tissue (Wharton's jelly) | allo-unrelated | no bone adhesion | orthopedics | 2017 | experimental therapy | Poland | 14 |
729 | cord tissue (Wharton's jelly) | allo-unrelated | traumatic brain injury | neurology | 2017 | experimental therapy | Poland | 9 |
730 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15 |
731 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 6 |
732 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, epilepsy | neurology | 2017 | experimental therapy | Poland | 5 |
733 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy, cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
734 | cord tissue (Wharton's jelly) | allo-unrelated | arthrogryposis multiplex congenita | neurology | 2017 | experimental therapy | Poland | 1 |
735 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 37 |
736 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 1 |
737 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 48 |
738 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 40 |
739 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61 |
740 | cord tissue (Wharton's jelly) | allo-unrelated | chronic myeloid leukemia | hematology | 2017 | experimental therapy | Poland | 5 |
741 | cord tissue (Wharton's jelly) | allo-unrelated | congenital fiber-type disproportion myopathy | neurology | 2017 | experimental therapy | Poland | 1 |
742 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 11 |
743 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 9 |
744 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 26 |
745 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 11 |
746 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy, neonatal cerebral leukomalacia | neurology | 2017 | experimental therapy | Poland | 1 |
747 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 52 |
748 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 41 |
749 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2017 | experimental therapy | Poland | 5 |
750 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2017 | experimental therapy | Poland | 21 |
751 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 13 |
752 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56 |
753 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 38 |
754 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 47 |
755 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 64 |
756 | cord tissue (Wharton's jelly) | allo-unrelated | syringomielia | neurology | 2017 | experimental therapy | Poland | 42 |
757 | cord tissue (Wharton's jelly) | allo-unrelated | transverse myelitis | neurology | 2017 | experimental therapy | Poland | 8 |
758 | cord tissue (Wharton's jelly) | allo-unrelated | cranium bifidum | neurology | 2017 | experimental therapy | Poland | 5 |
759 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 3 |
760 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 28 |
761 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 22 |
762 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59 |
763 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 18 |
764 | cord tissue (Wharton's jelly) | allo-unrelated | cri du chat syndrome | neurology | 2017 | experimental therapy | Poland | 8 |
765 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 58 |
766 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 8 |
767 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 12 |
768 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 30 |
769 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 42 |
770 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 39 |
771 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51 |
772 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 39 |
773 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43 |
774 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 23 |
775 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 75 |
776 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 25 |
777 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 41 |
778 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 44 |
779 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 28 |
780 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 45 |
781 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65 |
782 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 56 |
783 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 30 |
784 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 10 |
785 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 24 |
786 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | neurology | 2017 | experimental therapy | Poland | 29 |
787 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2017 | experimental therapy | Poland | 33 |
788 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 31 |
789 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2017 | experimental therapy | Poland | 23 |
790 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 52 |
791 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 34 |
792 | cord tissue (Wharton's jelly) | allo-unrelated | cartilage damage | orthopedics | 2017 | experimental therapy | Poland | 61 |
793 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46 |
794 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 48 |
795 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56 |
796 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 26 |
797 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 37 |
798 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 37 |
799 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 49 |
800 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 58 |
801 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 34 |
802 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 44 |
803 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 47 |
804 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 7 |
805 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | no data |
806 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 71 |
807 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 37 |
808 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 67 |
809 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
810 | cord tissue (Wharton's jelly) | allo-unrelated | premature ovarian failure | ginecology | 2016 | experimental therapy | Poland | 34 |
811 | cord tissue (Wharton's jelly) | allo-unrelated | premature ovarian failure | ginecology | 2016 | experimental therapy | Poland | 23 |
812 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60 |
813 | cord tissue (Wharton's jelly) | allo-unrelated | meniscus damage | orthopedics | 2016 | experimental therapy | Poland | 35 |
814 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 44 |
815 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 38 |
816 | cord tissue (Wharton's jelly) | allo-unrelated | endometrial atrophy | ginecology | 2016 | experimental therapy | Poland | 39 |
817 | cord tissue (Wharton's jelly) | allo-unrelated | endometrial atrophy | ginecology | 2016 | experimental therapy | Poland | 37 |
818 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 33 |
819 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 31 |
820 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 15 |
821 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /BMD | neurology | 2016 | experimental therapy | Poland | 19 |
822 | cord tissue (Wharton's jelly) | allo-unrelated | degeneration of the cartilage of the knee joint | orthopedics | 2016 | experimental therapy | Poland | 54 |
823 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 44 |
824 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
825 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis | orthopedics | 2016 | experimental therapy | Poland | 27 |
826 | cord tissue (Wharton's jelly) | allo-unrelated | neurodevelopmental disorders | neurology | 2016 | experimental therapy | Poland | 4 |
827 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2016 | experimental therapy | Poland | 28 |
828 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 4 |
829 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4 |
830 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 10 |
831 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 44 |
832 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 4 |
833 | cord tissue (Wharton's jelly) | allo-unrelated | cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 57 |
834 | cord tissue (Wharton's jelly) | allo-unrelated | injuries to the spinal nerves | neurology | 2016 | experimental therapy | Poland | below 1 |
835 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 17 |
836 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3 |
837 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 16 |
838 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 33 |
839 | cord tissue (Wharton's jelly) | allo-unrelated | myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 37 |
840 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 37 |
841 | cord tissue (Wharton's jelly) | allo-unrelated | diffuse cartilage damage left medial compartment of the knee | orthopedics | 2016 | experimental therapy | Poland | 50 |
842 | cord tissue (Wharton's jelly) | allo-unrelated | polineuropathy | neurology | 2016 | experimental therapy | Poland | 70 |
843 | cord tissue (Wharton's jelly) | allo-unrelated | epileptic encephalopathy | neurology | 2016 | experimental therapy | Poland | 3 |
844 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 14 |
845 | cord tissue (Wharton's jelly) | allo-unrelated | gangliosidosis t. 1 | neurology | 2016 | experimental therapy | Poland | 1 |
846 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | no data |
847 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
848 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56 |
849 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 48 |
850 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4 |
851 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 18 |
852 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 2 |
853 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56 |
854 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72 |
855 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 41 |
856 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
857 | cord tissue (Wharton's jelly) | allo-unrelated | chondronecrosis femoral condyle | orthopedics | 2016 | experimental therapy | Poland | 54 |
858 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 68 |
859 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 58 |
860 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 13 |
861 | cord tissue (Wharton's jelly) | allo-unrelated | fetal alcohol spectrum disorders | neurology | 2016 | experimental therapy | Poland | 5 |
862 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 20 |
863 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49 |
864 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 51 |
865 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 41 |
866 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
867 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 16 |
868 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 10 |
869 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 6 |
870 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 15 |
871 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
872 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 24 |
873 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 9 |
874 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 44 |
875 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2016 | experimental therapy | Poland | below 1 |
876 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 68 |
877 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 29 |
878 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 1 |
879 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 7 |
880 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 1 |
881 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 60 |
882 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 71 |
883 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 52 |
884 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 65 |
885 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 32 |
886 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 34 |
887 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 24 |
888 | cord tissue (Wharton's jelly) | allo-unrelated | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 53 |
889 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2016 | experimental therapy | Poland | 20 |
890 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 59 |
891 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | no data |
892 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2016 | experimental therapy | Poland | 4 |
893 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 2 |
894 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2016 | experimental therapy | Poland | 3 |
895 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10 |
896 | cord tissue (Wharton's jelly) | allo-unrelated | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 60 |
897 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53 |
898 | cord tissue (Wharton's jelly) | allo-unrelated | no data | ophthalmology | 2016 | experimental therapy | Poland | 66 |
899 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 31 |
900 | cord tissue (Wharton's jelly) | allo-unrelated | ataxia hereditaria | neurology | 2016 | experimental therapy | Poland | 69 |
901 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 31 |
902 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 37 |
903 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 17 |
904 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 30 |
905 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 34 |
906 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 59 |
907 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 3 |
908 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2016 | experimental therapy | Poland | 2 |
909 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 1 |
910 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 12 |
911 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12 |
912 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 5 |
913 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2 |
914 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 13 |
915 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 68 |
916 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 54 |
917 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2016 | experimental therapy | Poland | 86 |
918 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 23 |
919 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
920 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49 |
921 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 47 |
922 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 14 |
923 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 54 |
924 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 79 |
925 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3 |
926 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 8 |
927 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 38 |
928 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 66 |
929 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 7 |
930 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2016 | experimental therapy | Poland | 7 |
931 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 13 |
932 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 39 |
933 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
934 | cord tissue (Wharton's jelly) | allo-unrelated | global developmental delay | neurology | 2016 | experimental therapy | Poland | 6 |
935 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9 |
936 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3 |
937 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 1 |
938 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 4 |
939 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58 |
940 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
941 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49 |
942 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
943 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
944 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12 |
945 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 58 |
946 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 62 |
947 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
948 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 14 |
949 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 22 |
950 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 50 |
951 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54 |
952 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy | neurology | 2016 | experimental therapy | Poland | 9 |
953 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy | neurology | 2016 | experimental therapy | Poland | 6 |
954 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 48 |
955 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72 |
956 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 79 |
957 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
958 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 45 |
959 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 61 |
960 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 3 |
961 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 32 |
962 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 48 |
963 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
964 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2016 | experimental therapy | Poland | 2 |
965 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 73 |
966 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60 |
967 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 7 |
968 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 63 |
969 | cord tissue (Wharton's jelly) | allo-unrelated | choroideremia | ophthalmology | 2016 | experimental therapy | Poland | 50 |
970 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 49 |
971 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 41 |
972 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 33 |
973 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 54 |
974 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 55 |
975 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4 |
976 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2 |
977 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 51 |
978 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56 |
979 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 62 |
980 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2016 | experimental therapy | Poland | 2 |
981 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
982 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 38 |
983 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 64 |
984 | cord tissue (Wharton's jelly) | allo-unrelated | malformation syndrome | neurology | 2016 | experimental therapy | Poland | 3 |
985 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 64 |
986 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
987 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56 |
988 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54 |
989 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72 |
990 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 46 |
991 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
992 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49 |
993 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
994 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
995 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 36 |
996 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53 |
997 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 45 |
998 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 13 |
999 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 69 |
1000 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 69 |
1001 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 49 |
1002 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9 |
1003 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 11 |
1004 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
1005 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 60 |
1006 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 42 |
1007 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 14 |
1008 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis | orthopedics | 2016 | experimental therapy | Poland | 27 |
1009 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
1010 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
1011 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 19 |
1012 | cord tissue (Wharton's jelly) | allo-unrelated | traumatic brain injury | neurology | 2016 | experimental therapy | Poland | 54 |
1013 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2 |
1014 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 18 |
1015 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 47 |
1016 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 69 |
1017 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 34 |
1018 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60 |
1019 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 28 |
1020 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
1021 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 52 |
1022 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
1023 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58 |
1024 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
1025 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2016 | experimental therapy | Poland | 19 |
1026 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58 |
1027 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 46 |
1028 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53 |
1029 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54 |
1030 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 63 |
1031 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 10 |
1032 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 25 |
1033 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 44 |
1034 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
1035 | cord tissue (Wharton's jelly) | allo-unrelated | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 60 |
1036 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 39 |
1037 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 8 |
1038 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 25 |
1039 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 24 |
1040 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 20 |
1041 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 33 |
1042 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 69 |
1043 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 28 |
1044 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 7 |
1045 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 39 |
1046 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 37 |
1047 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 33 |
1048 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 29 |
1049 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 8 |
1050 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10 |
1051 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 22 |
1052 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 33 |
1053 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 53 |
1054 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2016 | experimental therapy | Poland | 20 |
1055 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9 |
1056 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 12 |
1057 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2 |
1058 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
1059 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
1060 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2016 | experimental therapy | Poland | 2 |
1061 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 65 |
1062 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 6 |
1063 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 14 |
1064 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2016 | experimental therapy | Poland | 3 |
1065 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12 |
1066 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53 |
1067 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 35 |
1068 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10 |
1069 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 48 |
1070 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 18 |
1071 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 62 |
1072 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 64 |
1073 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 32 |
1074 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60 |
1075 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 44 |
1076 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10 |
1077 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy, encephalopathy | neurology | 2015 | experimental therapy | Poland | 8 |
1078 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | encephalopathy | neurology | 2015 | experimental therapy | Poland | 11 |
1079 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 26 |
1080 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2015 | experimental therapy | Poland | 34 |
1081 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 16 |
1082 | cord tissue (Wharton's jelly) | allo-unrelated | anterior ischemic optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 54 |
1083 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 14 |
1084 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 1 |
1085 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 34 |
1086 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2015 | experimental therapy | Poland | 18 |
1087 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2015 | experimental therapy | Poland | 65 |
1088 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 24 |
1089 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2015 | experimental therapy | Poland | 54 |
1090 | cord tissue (Wharton's jelly) | allo-unrelated | intracranial injury | neurology | 2015 | experimental therapy | Poland | 24 |
1091 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 54 |
1092 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
1093 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 13 |
1094 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 9 |
1095 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 21 |
1096 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 48 |
1097 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 6 |
1098 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2015 | experimental therapy | Poland | below 1 |
1099 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 8 |
1100 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 46 |
1101 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2015 | experimental therapy | Poland | 26 |
1102 | cord tissue (Wharton's jelly) | allo-unrelated | severe developmental delay | neurology | 2015 | experimental therapy | Poland | 1 |
1103 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2015 | experimental therapy | Poland | 10 |
1104 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2015 | experimental therapy | Poland | 30 |
1105 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 58 |
1106 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2015 | experimental therapy | Poland | 62 |
1107 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 37 |
1108 | cord tissue (Wharton's jelly) | allo-unrelated | polineuropathy | neurology | 2015 | experimental therapy | Poland | 74 |
1109 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 5 |
1110 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 67 |
1111 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 24 |
1112 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 18 |
1113 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2015 | experimental therapy | Poland | 2 |
1114 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2015 | experimental therapy | Poland | 3 |
1115 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2015 | experimental therapy | Poland | 33 |
1116 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 22 |
1117 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 32 |
1118 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 63 |
1119 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 4 |
1120 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 6 |
1121 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 4 |
1122 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 27 |
1123 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 26 |
1124 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 12 |
1125 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 51 |
1126 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 62 |
1127 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 45 |
1128 | cord tissue (Wharton's jelly) | allo-unrelated | iatrogenic spinal cord injury | neurology | 2015 | experimental therapy | Poland | 17 |
1129 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2015 | experimental therapy | Poland | 66 |
1130 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
1131 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 15 |
1132 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 44 |
1133 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2015 | experimental therapy | Poland | below 1 |
1134 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 35 |
1135 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 58 |
1136 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 37 |
1137 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 26 |
1138 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 40 |
1139 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy | neurology | 2015 | experimental therapy | Poland | 11 |
1140 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy, encephalopathy | neurology | 2015 | experimental therapy | Poland | 23 |
1141 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 2 |
1142 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 18 |
1143 | cord tissue (Wharton's jelly) | allo-unrelated | traumatic encephalopathy | neurology | 2015 | experimental therapy | Poland | 20 |
1144 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
1145 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development, deafness | neurology | 2015 | experimental therapy | Poland | 3 |
1146 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 8 |
1147 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 12 |
1148 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 5 |
1149 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 31 |
1150 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 59 |
1151 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2015 | experimental therapy | Poland | 2 |
1152 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 13 |
1153 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 7 |
1154 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 3 |
1155 | cord tissue (Wharton's jelly) | allo-unrelated | ceroid lipofuscinosis | neurology | 2015 | experimental therapy | Poland | 7 |
1156 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2015 | experimental therapy | Poland | 14 |
1157 | cord tissue (Wharton's jelly) | allo-unrelated | ceroid lipofuscinosis | neurology | 2015 | experimental therapy | Poland | 5 |
1158 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 15 |
1159 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 7 |
1160 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | below 1 |
1161 | cord tissue (Wharton's jelly) | allo-unrelated | bilateral blindness | ophthalmology | 2015 | experimental therapy | Poland | 36 |
1162 | cord tissue (Wharton's jelly) | allo-unrelated | decerebration rigidity | neurology | 2015 | experimental therapy | Poland | 9 |
1163 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 3 |
1164 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 52 |
1165 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 60 |
1166 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 65 |
1167 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 51 |
1168 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 56 |
1169 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
1170 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
1171 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2015 | experimental therapy | Poland | 23 |
1172 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 5 |
1173 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 1 |
1174 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2014 | experimental therapy | Poland | 15 |
1175 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2014 | experimental therapy | Poland | 4 |
1176 | cord tissue (Wharton's jelly) | allo-unrelated | birth asphyxia, retinopathy | neurology | 2014 | experimental therapy | Poland | below 1 |
1177 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2014 | experimental therapy | Poland | 6 |
1178 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2014 | experimental therapy | Poland | 8 |
1179 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2014 | experimental therapy | Poland | 24 |
1180 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2014 | experimental therapy | Poland | 60 |
1181 | cord tissue (Wharton's jelly) | allo-unrelated | central motor coordination impairment after hypoxic ischaemia lesion at birth | neurology | 2014 | experimental therapy | Poland | 2 |
1182 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2014 | experimental therapy | Poland | 6 |
1183 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2014 | experimental therapy | Poland | 12 |
1184 | cord tissue (Wharton's jelly) | allo-unrelated | neuropathy | neurology | 2014 | experimental therapy | Poland | 23 |
1185 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2013 | experimental therapy | Poland | 17 |
1186 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2013 | experimental therapy | Poland | 18 |
1187 | cord tissue (Wharton's jelly) | allo-unrelated | acute myeloid leukemia | hematology | 2013 | experimental therapy | Poland | 3 |
1188 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 3 |
1189 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 2 |
1190 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 18 |
1191 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 4 |
1192 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 7 |
1193 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 19 |
1194 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2011 | experimental therapy | Poland | 17 |
1195 | bone marrow | allogeneic | Fanconi Aplastic Anemia | hematology | 2019 | standard therapy | Turkey | 6 |
1196 | bone marrow | allogeneic | no data | hematology | 2019 | standard therapy | United Kingdom | 3 |
1197 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 66 |
1198 | bone marrow | allogeneic | aplastic anaemia | hematology | 2019 | standard therapy | Romania | 8 |
1199 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Poland | 5 |
1200 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | USA | 52 |
1201 | bone marrow | allogeneic | no data | hematology | 2019 | standard therapy | Italy | 59 |
1202 | bone marrow | allogeneic | aplastic anaemia | hematology | 2019 | standard therapy | Canada | 18 |
1203 | bone marrow | allogeneic | acute lymphoblastic leukemia relapse | hematology | 2018 | standard therapy | Germany | 14 |
1204 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 53 |
1205 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Turkey | 21 |
1206 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | Brazil | 1 |
1207 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 60 |
1208 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 22 |
1209 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Canada | 37 |
1210 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Canada | 18 |
1211 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Iran | 6 |
1212 | bone marrow | allogeneic | congenital hypoplastic anemia | hematology | 2018 | standard therapy | Canada | 2 |
1213 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Germany | 20 |
1214 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2018 | standard therapy | Brazil | 3 |
1215 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 6 |
1216 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 40 |
1217 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
1218 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | USA | 1 |
1219 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | Germany | 1 |
1220 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 31 |
1221 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 52 |
1222 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 12 |
1223 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 2 |
1224 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Australia | 59 |
1225 | bone marrow | allogeneic | other non-malignant disease | hematology | 2018 | standard therapy | USA | 29 |
1226 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | United Kingdom | 6 |
1227 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Poland | 18 |
1228 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 8 |
1229 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Poland | below 1 |
1230 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 14 |
1231 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 70 |
1232 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Hungary | 4 |
1233 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 4 |
1234 | bone marrow | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 62 |
1235 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 66 |
1236 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 25 |
1237 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | USA | 2 |
1238 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 17 |
1239 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 32 |
1240 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Austria | 8 |
1241 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 7 |
1242 | bone marrow | allogeneic | T-cell leukemia/lymphoma | hematology | 2018 | standard therapy | Argentina | 10 |
1243 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Belgium | 41 |
1244 | bone marrow | allogeneic | thalassemia major | hematology | 2018 | standard therapy | Turkey | 12 |
1245 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 66 |
1246 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 3 |
1247 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | India | 27 |
1248 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 49 |
1249 | bone marrow | allogeneic | aplastic anaemia | hematology | 2018 | standard therapy | Poland | 24 |
1250 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 70 |
1251 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | France | 2 |
1252 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 71 |
1253 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 8 |
1254 | bone marrow | allogeneic | Hurler syndrome | hematology | 2018 | standard therapy | USA | 2 |
1255 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 12 |
1256 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2018 | standard therapy | USA | 3 |
1257 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 1 |
1258 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Canada | 8 |
1259 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 20 |
1260 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | USA | 1 |
1261 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | USA | 2 |
1262 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Argentina | 14 |
1263 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 11 |
1264 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Italy | 14 |
1265 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Israel | 2 |
1266 | bone marrow | allogeneic | diffuse large B-cell lymphoma | hematology | 2018 | standard therapy | Germany | 68 |
1267 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 50 |
1268 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 19 |
1269 | bone marrow | allogeneic | thalassemia major | hematology | 2018 | standard therapy | Sweden | 14 |
1270 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 36 |
1271 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 12 |
1272 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 16 |
1273 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | Spain | 48 |
1274 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Brazil | 3 |
1275 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Switzerland | 67 |
1276 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | below 1 |
1277 | bone marrow | allogeneic | bilineal leukemia -acute lymphoblastic leukemia, acute myelogenous leukemia | hematology | 2018 | standard therapy | Belarus | 2 |
1278 | bone marrow | allogeneic | Hodgkin’s lymphoma | hematology | 2018 | standard therapy | USA | 31 |
1279 | bone marrow | allogeneic | juvenile myelomonocytic leukemia | hematology | 2018 | standard therapy | Hungary | 11 |
1280 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | Switzerland | 3 |
1281 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 4 |
1282 | bone marrow | allogeneic | primary Immunodeficiency, Nijmegen breakage syndrome | hematology | 2017 | standard therapy | Belarus | 6 |
1283 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 19 |
1284 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Hungary | 7 |
1285 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2017 | standard therapy | Belarus | 10 |
1286 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 8 |
1287 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 2 |
1288 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 18 |
1289 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | India | 7 |
1290 | bone marrow | allogeneic | secondary acute myelogenous leukemia after Ewing sarcoma | hematology | 2017 | standard therapy | Germany | 16 |
1291 | bone marrow | allogeneic | Nijmegen breakage syndrome | hematology | 2017 | standard therapy | Poland | 8 |
1292 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Norway | 2 |
1293 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 12 |
1294 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 2 |
1295 | bone marrow | allogeneic | other combined immunodeficiency | hematology | 2017 | standard therapy | USA | 11 |
1296 | bone marrow | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | Canada | 50 |
1297 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 7 |
1298 | bone marrow | allogeneic | T-cell leukemia/lymphoma | hematology | 2017 | standard therapy | Iran | 18 |
1299 | bone marrow | allogeneic | Wiskott-Aldrich syndrome | hematology | 2017 | standard therapy | Iran | 2 |
1300 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 4 |
1301 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Brazil | 14 |
1302 | bone marrow | allogeneic | no data | hematology | 2017 | standard therapy | France | 32 |
1303 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 9 |
1304 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 8 |
1305 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Poland | 1 |
1306 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 24 |
1307 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 54 |
1308 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 56 |
1309 | bone marrow | allogeneic | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 51 |
1310 | bone marrow | allogeneic | acute megakaryocytic leukemia | hematology | 2017 | standard therapy | Spain | 2 |
1311 | bone marrow | allogeneic | juvenile myelomonocytic leukemia | hematology | 2017 | standard therapy | Finland | 1 |
1312 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
1313 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 17 |
1314 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 10 |
1315 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2017 | standard therapy | Russia | 10 |
1316 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 60 |
1317 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 68 |
1318 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 10 |
1319 | bone marrow | allogeneic | thalassemia major | hematology | 2017 | standard therapy | Turkey | 11 |
1320 | bone marrow | allogeneic | pure red cell aplasia | hematology | 2017 | standard therapy | USA | 5 |
1321 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
1322 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 59 |
1323 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 1 |
1324 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Austria | 3 |
1325 | bone marrow | allogeneic | hyper IgM syndrome | hematology | 2017 | standard therapy | Finland | 2 |
1326 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 2 |
1327 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 21 |
1328 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 59 |
1329 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Canada | 1 |
1330 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 9 |
1331 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 38 |
1332 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 13 |
1333 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Lithuania | 1 |
1334 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 16 |
1335 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 67 |
1336 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 55 |
1337 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 6 |
1338 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Hungary | 14 |
1339 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 10 |
1340 | bone marrow | allogeneic | leukemia | hematology | 2017 | standard therapy | USA | 40 |
1341 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 4 |
1342 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Russia | 30 |
1343 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 61 |
1344 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Italy | 60 |
1345 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
1346 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 2 |
1347 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 22 |
1348 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 76 |
1349 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 6 |
1350 | bone marrow | allogeneic | high-risk acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 18 |
1351 | bone marrow | allogeneic | anaemia | hematology | 2016 | standard therapy | Italy | 5 |
1352 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 6 |
1353 | bone marrow | allogeneic | anaemia | hematology | 2016 | standard therapy | Germany | 16 |
1354 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Finland | 45 |
1355 | bone marrow | allogeneic | juvenile myelomonocytic leukemia | hematology | 2016 | standard therapy | Germany | 3 |
1356 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 15 |
1357 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 9 |
1358 | bone marrow | allogeneic | Diamond-Balckfan anaemia | hematology | 2016 | standard therapy | Germany | 2 |
1359 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Ireland | 39 |
1360 | bone marrow | allogeneic | myeloproliferative syndrome | hematology | 2016 | standard therapy | Poland | 22 |
1361 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Croatia | 33 |
1362 | bone marrow | allogeneic | aplastic anaemia | hematology | 2016 | standard therapy | Austria | 20 |
1363 | bone marrow | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Italy | 46 |
1364 | bone marrow | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 33 |
1365 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 5 |
1366 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2016 | standard therapy | Germany | 12 |
1367 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | New Zealand | 1 |
1368 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 25 |
1369 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 29 |
1370 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 5 |
1371 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2016 | standard therapy | Netherlands | 41 |
1372 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Spain | 56 |
1373 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 67 |
1374 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Hungary | 1 |
1375 | bone marrow | allogeneic | severe aplastic anaemia / paroxymal nocturnal haemoglobinuria | hematology | 2016 | standard therapy | Poland | 17 |
1376 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2016 | standard therapy | France | 9 |
1377 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2016 | standard therapy | Poland | below 1 |
1378 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 18 |
1379 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Belarus | 12 |
1380 | bone marrow | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Italy | 17 |
1381 | bone marrow | allogeneic | DiGeorge syndrome | hematology | 2016 | standard therapy | Netherlands | 24 |
1382 | bone marrow | allogeneic | myelofibrosis | hematology | 2016 | standard therapy | Germany | 31 |
1383 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Canada | 11 |
1384 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2016 | standard therapy | Turkey | 4 |
1385 | bone marrow | allogeneic | Hurler syndrome | metabolic | 2016 | standard therapy | United Kingdom | 2 |
1386 | bone marrow | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 7 |
1387 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2016 | standard therapy | France | 9 |
1388 | bone marrow | allogeneic | osteopetrosis | metabolic | 2016 | standard therapy | Germany | 1 |
1389 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 7 |
1390 | bone marrow | allogeneic | biphenotypic leukemia | hematology | 2016 | standard therapy | Brazil | 27 |
1391 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 14 |
1392 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 64 |
1393 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 6 |
1394 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2016 | standard therapy | Estonia | 7 |
1395 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 55 |
1396 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 9 |
1397 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 64 |
1398 | bone marrow | allogeneic | no data | n/a | 2016 | standard therapy | Italy | 3 |
1399 | bone marrow | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 4 |
1400 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2016 | standard therapy | Romania | 2 |
1401 | bone marrow | allogeneic | osteopetrosis | metabolic | 2016 | standard therapy | Russia | 6 |
1402 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Ireland | 38 |
1403 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2019 | standard therapy | Finland | 48 |
1404 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Australia | 57 |
1405 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2019 | standard therapy | Turkey | 54 |
1406 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Poland | 62 |
1407 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 53 |
1408 | peripheral blood | allogeneic | no data | hematology | 2019 | standard therapy | Poland | 43 |
1409 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2019 | standard therapy | USA | 65 |
1410 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Istanbul | 4 |
1411 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 55 |
1412 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2019 | standard therapy | USA | 58 |
1413 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 36 |
1414 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 54 |
1415 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Belgium | 62 |
1416 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 37 |
1417 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 62 |
1418 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 66 |
1419 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 53 |
1420 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Turkey | 39 |
1421 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Czech Republic | 65 |
1422 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2019 | standard therapy | Chile | 12 |
1423 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 63 |
1424 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 38 |
1425 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 67 |
1426 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 66 |
1427 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Greece | 46 |
1428 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | France | 67 |
1429 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 62 |
1430 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 14 |
1431 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 24 |
1432 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Lithuania | 46 |
1433 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Poland | 60 |
1434 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 61 |
1435 | peripheral blood | allogeneic | peripheral T-cell lymphoma | hematology | 2018 | standard therapy | Germany | 50 |
1436 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 63 |
1437 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Greece | 47 |
1438 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 41 |
1439 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 58 |
1440 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 8 |
1441 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Lithuania | 9 |
1442 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Greece | 45 |
1443 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 67 |
1444 | peripheral blood | allogeneic | atypical chronic myeloid leukemia | hematology | 2018 | standard therapy | USA | 58 |
1445 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Germany | 52 |
1446 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2018 | standard therapy | Poland | 27 |
1447 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Turkey | 61 |
1448 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 62 |
1449 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Slovakia | 56 |
1450 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 55 |
1451 | peripheral blood | allogeneic | myelodysplastic syndrome - RAEB | hematology | 2018 | standard therapy | Germany | 61 |
1452 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 34 |
1453 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Poland | 53 |
1454 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Lithuania | 52 |
1455 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Greece | 46 |
1456 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 55 |
1457 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Romania | 37 |
1458 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Italy | 49 |
1459 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
1460 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 20 |
1461 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Greece | 43 |
1462 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 75 |
1463 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 34 |
1464 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Poland | 54 |
1465 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 8 |
1466 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Argentina | 25 |
1467 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 59 |
1468 | peripheral blood | allogeneic | non-Hodgkin lymphoma, diffuse large B-cell lymphoma | hematology | 2018 | standard therapy | Germany | 62 |
1469 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Slovakia | 40 |
1470 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Bulgaria | 57 |
1471 | peripheral blood | allogeneic | Chronic granulomatous disease | hematology | 2018 | standard therapy | Russia | 2 |
1472 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 63 |
1473 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Macedonia | 22 |
1474 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | USA | 72 |
1475 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 34 |
1476 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 40 |
1477 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | United Kingdom | 69 |
1478 | peripheral blood | allogeneic | Hypoplastic MDS-EB2 with incipient sAML | hematology | 2018 | standard therapy | Germany | 63 |
1479 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 65 |
1480 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 59 |
1481 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 13 |
1482 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 54 |
1483 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 66 |
1484 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 54 |
1485 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 67 |
1486 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Germany | 45 |
1487 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 48 |
1488 | peripheral blood | allogeneic | plasma cell disorder | hematology | 2018 | standard therapy | France | 57 |
1489 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Poland | 30 |
1490 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 68 |
1491 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 4 |
1492 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2018 | standard therapy | United Kingdom | 41 |
1493 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Netherlands | 67 |
1494 | peripheral blood | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Poland | 2 |
1495 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 34 |
1496 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 64 |
1497 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | USA | 67 |
1498 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Belgium | 49 |
1499 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 30 |
1500 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 60 |
1501 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 52 |
1502 | peripheral blood | allogeneic | prolymphocytic leukemia | hematology | 2018 | standard therapy | USA | 62 |
1503 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 32 |
1504 | peripheral blood | allogeneic | B-cell Chronic lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 65 |
1505 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Spain | 46 |
1506 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Czech Republic | 57 |
1507 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 55 |
1508 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Belgium | 58 |
1509 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 19 |
1510 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 60 |
1511 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 45 |
1512 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 58 |
1513 | peripheral blood | allogeneic | myeloproliferative neoplasms | hematology | 2018 | standard therapy | Germany | 61 |
1514 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Spain | 51 |
1515 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Canada | 60 |
1516 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 59 |
1517 | peripheral blood | allogeneic | therapy-related myelodysplastic syndromes | hematology | 2018 | standard therapy | Germany | 65 |
1518 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Germany | 11 |
1519 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2018 | standard therapy | USA | 25 |
1520 | peripheral blood | allogeneic | follicular lymphoma (non-Hodgkin lymphoma) | hematology | 2018 | standard therapy | Czech Republic | 56 |
1521 | peripheral blood | allogeneic | thalassemia major | hematology | 2018 | standard therapy | Germany | 5 |
1522 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 44 |
1523 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Netherlands | 31 |
1524 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 71 |
1525 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 48 |
1526 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 20 |
1527 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Russia | 6 |
1528 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 56 |
1529 | peripheral blood | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | USA | 15 |
1530 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 66 |
1531 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 49 |
1532 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 6 |
1533 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 60 |
1534 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 65 |
1535 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 57 |
1536 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 67 |
1537 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | USA | 68 |
1538 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 36 |
1539 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 37 |
1540 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 29 |
1541 | peripheral blood | allogeneic | other malignancy | hematology | 2018 | standard therapy | Italy | 59 |
1542 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 47 |
1543 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2018 | standard therapy | USA | 48 |
1544 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 46 |
1545 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 64 |
1546 | peripheral blood | allogeneic | primary Immunodeficiency | hematology | 2018 | standard therapy | Russia | 3 |
1547 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 55 |
1548 | peripheral blood | allogeneic | relapsed peripheral T cell lymphoma | hematology | 2018 | standard therapy | Canada | 44 |
1549 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 62 |
1550 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 71 |
1551 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 52 |
1552 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2018 | standard therapy | Italy | 38 |
1553 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Canada | 63 |
1554 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 28 |
1555 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 67 |
1556 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 69 |
1557 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Denmark | 59 |
1558 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 63 |
1559 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Czech Republic | 22 |
1560 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 71 |
1561 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 70 |
1562 | peripheral blood | allogeneic | other myelodysplastic syndromes | hematology | 2018 | standard therapy | USA | 67 |
1563 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Israel | 32 |
1564 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Austria | 45 |
1565 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Sweden | 60 |
1566 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 64 |
1567 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Poland | 71 |
1568 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Belgium | 64 |
1569 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 38 |
1570 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 59 |
1571 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Italy | 58 |
1572 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 32 |
1573 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2018 | standard therapy | Poland | 49 |
1574 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Turkey | 60 |
1575 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 46 |
1576 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 25 |
1577 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 71 |
1578 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 31 |
1579 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2018 | standard therapy | Sweden | 63 |
1580 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | below 1 |
1581 | peripheral blood | allogeneic | follicular lymphoma | hematology | 2018 | standard therapy | Lithuania | 44 |
1582 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 50 |
1583 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 17 |
1584 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 54 |
1585 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Poland | 24 |
1586 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Belgium | 27 |
1587 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 39 |
1588 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Netherlands | 56 |
1589 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Serbia | 39 |
1590 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Netherlands | 66 |
1591 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Sutherland | 59 |
1592 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Lithuania | 21 |
1593 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 67 |
1594 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 33 |
1595 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 70 |
1596 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Spain | 53 |
1597 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 45 |
1598 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 74 |
1599 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Brazil | 39 |
1600 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 27 |
1601 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Brazil | 3 |
1602 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 58 |
1603 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Bulgaria | 61 |
1604 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 40 |
1605 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 70 |
1606 | peripheral blood | allogeneic | plasma cell disorder | hematology | 2018 | standard therapy | France | 64 |
1607 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Russia | 33 |
1608 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 61 |
1609 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Brazil | 71 |
1610 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 55 |
1611 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
1612 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Hungary | 42 |
1613 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Canada | 58 |
1614 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 38 |
1615 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 63 |
1616 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 63 |
1617 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Belgium | 32 |
1618 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 56 |
1619 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Argentina | 1 |
1620 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Germany | 57 |
1621 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 62 |
1622 | peripheral blood | allogeneic | blastic NK cell lymphoma | hematology | 2018 | standard therapy | Germany | 65 |
1623 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 42 |
1624 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Belgium | 70 |
1625 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 3 |
1626 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | France | 70 |
1627 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Italy | 55 |
1628 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 8 |
1629 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 54 |
1630 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 33 |
1631 | peripheral blood | allogeneic | diffuse large B-cell lymphoma | hematology | 2018 | standard therapy | Poland | 54 |
1632 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Poland | 69 |
1633 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 35 |
1634 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 57 |
1635 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Turkey | 27 |
1636 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 66 |
1637 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 52 |
1638 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Lithuania | 39 |
1639 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 20 |
1640 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 67 |
1641 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 68 |
1642 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 73 |
1643 | peripheral blood | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Turkey | 9 |
1644 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 67 |
1645 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 33 |
1646 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 60 |
1647 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 60 |
1648 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Croatia | 59 |
1649 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 65 |
1650 | peripheral blood | allogeneic | myelodysplastic syndrome, acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 74 |
1651 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 37 |
1652 | peripheral blood | allogeneic | leukemia | hematology | 2018 | standard therapy | Germany | 34 |
1653 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 66 |
1654 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Belgium | 68 |
1655 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 28 |
1656 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 49 |
1657 | peripheral blood | allogeneic | Fanconi anaemia | hematology | 2018 | standard therapy | USA | 9 |
1658 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | USA | 63 |
1659 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 31 |
1660 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Germany | 17 |
1661 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Sweden | 60 |
1662 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Sweden | 56 |
1663 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 25 |
1664 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | USA | 39 |
1665 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 71 |
1666 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 60 |
1667 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 70 |
1668 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Switzerland | 50 |
1669 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Canada | 23 |
1670 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 69 |
1671 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 77 |
1672 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 58 |
1673 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 8 |
1674 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 38 |
1675 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 64 |
1676 | peripheral blood | allogeneic | primary myelofibrosis, secondary acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 53 |
1677 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 50 |
1678 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 76 |
1679 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 46 |
1680 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 61 |
1681 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | USA | 57 |
1682 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 64 |
1683 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Slovenia | 54 |
1684 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | United Kingdom | 22 |
1685 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 67 |
1686 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 54 |
1687 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 8 |
1688 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 62 |
1689 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 68 |
1690 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 13 |
1691 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 41 |
1692 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 62 |
1693 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 64 |
1694 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 47 |
1695 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 50 |
1696 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 61 |
1697 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 64 |
1698 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 51 |
1699 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 61 |
1700 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 59 |
1701 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 72 |
1702 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 54 |
1703 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 56 |
1704 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Netherlands | 67 |
1705 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 42 |
1706 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 71 |
1707 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 30 |
1708 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 67 |
1709 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 45 |
1710 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 45 |
1711 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 61 |
1712 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 33 |
1713 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 50 |
1714 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
1715 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Germany | 60 |
1716 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Spain | 34 |
1717 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2018 | standard therapy | Poland | 38 |
1718 | peripheral blood | allogeneic | acute myeloid leukemia in first complete remission | hematology | 2018 | standard therapy | Germany | 61 |
1719 | peripheral blood | allogeneic | secondary acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 58 |
1720 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 46 |
1721 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 48 |
1722 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 65 |
1723 | peripheral blood | allogeneic | other myleofibrosis | hematology | 2018 | standard therapy | Poland | 57 |
1724 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 66 |
1725 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Poland | 23 |
1726 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 46 |
1727 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 63 |
1728 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Lithuania | 56 |
1729 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 7 |
1730 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Germany | 18 |
1731 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 74 |
1732 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 42 |
1733 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | United Kingdom | 29 |
1734 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Netherlands | 49 |
1735 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 59 |
1736 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 35 |
1737 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 26 |
1738 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 13 |
1739 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 71 |
1740 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Switzerland | 68 |
1741 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 8 |
1742 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 37 |
1743 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Belgium | 26 |
1744 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 10 |
1745 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 70 |
1746 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 60 |
1747 | peripheral blood | allogeneic | myelodysplastic syndrome in Fanconi anaemia | hematology | 2017 | standard therapy | Italy | 23 |
1748 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 57 |
1749 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2017 | standard therapy | USA | 25 |
1750 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 72 |
1751 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 24 |
1752 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 63 |
1753 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 72 |
1754 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 69 |
1755 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 57 |
1756 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | Poland | 38 |
1757 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 27 |
1758 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 69 |
1759 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 40 |
1760 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Canada | 22 |
1761 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 61 |
1762 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | USA | 57 |
1763 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 64 |
1764 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Canada | 55 |
1765 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 61 |
1766 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 58 |
1767 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 72 |
1768 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
1769 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 71 |
1770 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 55 |
1771 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 68 |
1772 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 46 |
1773 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 26 |
1774 | peripheral blood | allogeneic | secondary acute myelogenous leukemia | hematology | 2017 | standard therapy | Austria | 24 |
1775 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2017 | standard therapy | Russia | 16 |
1776 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Israel | 6 |
1777 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 23 |
1778 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Israel | 37 |
1779 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 63 |
1780 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 59 |
1781 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 50 |
1782 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
1783 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 68 |
1784 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Netherlands | 65 |
1785 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 55 |
1786 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 67 |
1787 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 66 |
1788 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Poland | 1 |
1789 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 69 |
1790 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 53 |
1791 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 66 |
1792 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 52 |
1793 | peripheral blood | allogeneic | blastic plasmacytoid dendritic cell neoplasm | hematology | 2017 | standard therapy | Germany | 56 |
1794 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | USA | 47 |
1795 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
1796 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 24 |
1797 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2017 | standard therapy | Poland | 32 |
1798 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 71 |
1799 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 64 |
1800 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 21 |
1801 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Germany | 7 |
1802 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
1803 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
1804 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 43 |
1805 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Norway | 56 |
1806 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 51 |
1807 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 69 |
1808 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Netherlands | 72 |
1809 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | France | 36 |
1810 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Spain | 28 |
1811 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Greece | 28 |
1812 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 17 |
1813 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 16 |
1814 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
1815 | peripheral blood | allogeneic | prolymphocytic leukemia | hematology | 2017 | standard therapy | Poland | 63 |
1816 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Italy | 61 |
1817 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 63 |
1818 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 59 |
1819 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
1820 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2017 | standard therapy | Germany | 29 |
1821 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 46 |
1822 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
1823 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 56 |
1824 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 68 |
1825 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | United Kingdom | 51 |
1826 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Finland | 58 |
1827 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Netherlands | 53 |
1828 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 40 |
1829 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 61 |
1830 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 54 |
1831 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 57 |
1832 | peripheral blood | allogeneic | other malignancy | hematology | 2017 | standard therapy | France | 59 |
1833 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Lithuania | 53 |
1834 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 44 |
1835 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 32 |
1836 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 22 |
1837 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
1838 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 27 |
1839 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 49 |
1840 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 60 |
1841 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 64 |
1842 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 31 |
1843 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
1844 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 30 |
1845 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 74 |
1846 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Poland | 52 |
1847 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 64 |
1848 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 70 |
1849 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Poland | 53 |
1850 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 35 |
1851 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
1852 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
1853 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 60 |
1854 | peripheral blood | allogeneic | primary Immunodeficiency | hematology | 2017 | standard therapy | Russia | 2 |
1855 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
1856 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 49 |
1857 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 41 |
1858 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 52 |
1859 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 76 |
1860 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 68 |
1861 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 55 |
1862 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 25 |
1863 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Poland | 58 |
1864 | peripheral blood | allogeneic | myeloproliferative neoplasms | hematology | 2017 | standard therapy | Poland | 7 |
1865 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 42 |
1866 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 4 |
1867 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Israel | 11 |
1868 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Netherlands | 69 |
1869 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 68 |
1870 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 43 |
1871 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Switzerland | 67 |
1872 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 19 |
1873 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 69 |
1874 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Netherlands | 51 |
1875 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 58 |
1876 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 67 |
1877 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | USA | 58 |
1878 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 65 |
1879 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 62 |
1880 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 39 |
1881 | peripheral blood | allogeneic | primary Immunodeficiency | hematology | 2017 | standard therapy | Russia | 4 |
1882 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | France | 63 |
1883 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 63 |
1884 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Kanada | 32 |
1885 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
1886 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 7 |
1887 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Poland | 36 |
1888 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 32 |
1889 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 38 |
1890 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 38 |
1891 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 49 |
1892 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 60 |
1893 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Netherlands | 51 |
1894 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Turkey | 54 |
1895 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 58 |
1896 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Russia | 36 |
1897 | peripheral blood | allogeneic | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 4 |
1898 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Germany | 65 |
1899 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 29 |
1900 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Czech Republic | 12 |
1901 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 63 |
1902 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Germany | 29 |
1903 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Finland | 46 |
1904 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 35 |
1905 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Slovakia | 54 |
1906 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 23 |
1907 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 65 |
1908 | peripheral blood | allogeneic | prolymphocytic leukemia | hematology | 2017 | standard therapy | Belgium | 38 |
1909 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 54 |
1910 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 39 |
1911 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 69 |
1912 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 64 |
1913 | peripheral blood | allogeneic | other myleofibrosis | hematology | 2017 | standard therapy | USA | 71 |
1914 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 35 |
1915 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 65 |
1916 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Canada | 63 |
1917 | peripheral blood | allogeneic | follicular CA | hematology | 2017 | standard therapy | South Africa | 42 |
1918 | peripheral blood | allogeneic | acute myelogenous leukemia with myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 64 |
1919 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 62 |
1920 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 55 |
1921 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 53 |
1922 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 48 |
1923 | peripheral blood | allogeneic | β - thalassemia major | hematology | 2017 | standard therapy | India | 4 |
1924 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 67 |
1925 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 67 |
1926 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 59 |
1927 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 62 |
1928 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | United Kingdom | 55 |
1929 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 59 |
1930 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 52 |
1931 | peripheral blood | allogeneic | myeloproliferative neoplasms | hematology | 2017 | standard therapy | Poland | 7 |
1932 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 68 |
1933 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Belgium | 34 |
1934 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 70 |
1935 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Estonia | 67 |
1936 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 30 |
1937 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
1938 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 69 |
1939 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Switzerland | 75 |
1940 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Lithuania | 65 |
1941 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 56 |
1942 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 55 |
1943 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 56 |
1944 | peripheral blood | allogeneic | osteopetrosis | hematology | 2017 | standard therapy | Israel | 3 |
1945 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Poland | 47 |
1946 | peripheral blood | allogeneic | B-cell Chronic lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 48 |
1947 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
1948 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Germany | 56 |
1949 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 64 |
1950 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 33 |
1951 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 67 |
1952 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 53 |
1953 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 60 |
1954 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
1955 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 42 |
1956 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 75 |
1957 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 32 |
1958 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 54 |
1959 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Italy | 58 |
1960 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 57 |
1961 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 50 |
1962 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
1963 | peripheral blood | allogeneic | aplastic anaemia | hematology | 2017 | standard therapy | United Kingdom | 23 |
1964 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Poland | 39 |
1965 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Belgium | 55 |
1966 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 46 |
1967 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 71 |
1968 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 64 |
1969 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 65 |
1970 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 45 |
1971 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Belgium | 19 |
1972 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Norway | 57 |
1973 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Brazil | 12 |
1974 | peripheral blood | allogeneic | hemophagocytosis | hematology | 2017 | standard therapy | USA | 52 |
1975 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 45 |
1976 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Lithuania | 59 |
1977 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | Germany | 56 |
1978 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 60 |
1979 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 63 |
1980 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 61 |
1981 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 75 |
1982 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 66 |
1983 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 53 |
1984 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 46 |
1985 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 44 |
1986 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Germany | 66 |
1987 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Croatia | 64 |
1988 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Spain | 20 |
1989 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 3 |
1990 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Italy | 47 |
1991 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | France | 56 |
1992 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 48 |
1993 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | France | 43 |
1994 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 47 |
1995 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 53 |
1996 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 32 |
1997 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Belgium | 57 |
1998 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Slovakia | 64 |
1999 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 75 |
2000 | peripheral blood | allogeneic | Langerhans Lymphohistiocytosis | hematology | 2017 | standard therapy | Czech Republic | 2 |
2001 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 54 |
2002 | peripheral blood | allogeneic | no data | n/a | 2017 | standard therapy | France | 39 |
2003 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 47 |
2004 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Denmark | 63 |
2005 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Austria | 54 |
2006 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 48 |
2007 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 56 |
2008 | peripheral blood | allogeneic | diffuse large B-cell lymphoma | hematology | 2017 | standard therapy | Germany | 61 |
2009 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Spain | 63 |
2010 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 65 |
2011 | peripheral blood | allogeneic | Common variable immunodeficiency, relapsed hemophagocytic syndrome | hematology | 2017 | standard therapy | Germany | 44 |
2012 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 63 |
2013 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 3 |
2014 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Iran | 17 |
2015 | peripheral blood | allogeneic | Niemann–Pick disease | hematology | 2017 | standard therapy | Poland | 2 |
2016 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 14 |
2017 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2017 | standard therapy | Turkey | 29 |
2018 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 68 |
2019 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 43 |
2020 | peripheral blood | allogeneic | chronic myeloproliferative neoplasm blast crisis | hematology | 2017 | standard therapy | Germany | 29 |
2021 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | United Kingdom | 51 |
2022 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 24 |
2023 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 60 |
2024 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | Germany | 44 |
2025 | peripheral blood | allogeneic | Hurler syndrome | hematology | 2017 | standard therapy | United Kingdom | 2 |
2026 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 66 |
2027 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2016 | standard therapy | Russia | 18 |
2028 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 35 |
2029 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | USA | 69 |
2030 | peripheral blood | allogeneic | T-cell-prolymphocytic leukemia | hematology | 2016 | standard therapy | United Kingdom | 61 |
2031 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 19 |
2032 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 63 |
2033 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 62 |
2034 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 67 |
2035 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Canada | 47 |
2036 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 47 |
2037 | peripheral blood | allogeneic | plasma cell disorder | hematology | 2016 | standard therapy | France | 54 |
2038 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 50 |
2039 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 21 |
2040 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Netherlands | 39 |
2041 | peripheral blood | allogeneic | acute myelogenous leukemia M2/M4 | hematology | 2016 | standard therapy | Germany | 59 |
2042 | peripheral blood | allogeneic | high-risk acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 5 |
2043 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Italy | 58 |
2044 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 33 |
2045 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 30 |
2046 | peripheral blood | allogeneic | composite lymphoma | hematology | 2016 | standard therapy | Germany | 51 |
2047 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 55 |
2048 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 62 |
2049 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Russia | 32 |
2050 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 59 |
2051 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Russia | 44 |
2052 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 37 |
2053 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 15 |
2054 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2016 | standard therapy | Germany | 40 |
2055 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Greece | 9 |
2056 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 24 |
2057 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 54 |
2058 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 56 |
2059 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 63 |
2060 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 68 |
2061 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 72 |
2062 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Poland | 58 |
2063 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belgium | 44 |
2064 | peripheral blood | allogeneic | myelofibrosis | hematology | 2016 | standard therapy | France | 67 |
2065 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 20 |
2066 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Russia | 38 |
2067 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 66 |
2068 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 50 |
2069 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2016 | standard therapy | Finland | 46 |
2070 | peripheral blood | allogeneic | SAA / Amyloidosis | hematology | 2016 | standard therapy | United Kingdom | 45 |
2071 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | France | 59 |
2072 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Portugal | 41 |
2073 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 65 |
2074 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Australia | 62 |
2075 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | New Zealand | 59 |
2076 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Austria | 61 |
2077 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 39 |
2078 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2016 | standard therapy | Poland | 38 |
2079 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Belgium | 9 |
2080 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Slovakia | 30 |
2081 | peripheral blood | allogeneic | lymphoblastic lymphoma | hematology | 2016 | standard therapy | Italy | 33 |
2082 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 53 |
2083 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 65 |
2084 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 28 |
2085 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 51 |
2086 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 61 |
2087 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | France | 60 |
2088 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Brazil | 37 |
2089 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | United Kingdom | 20 |
2090 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2016 | standard therapy | Switzerland | 67 |
2091 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Austria | 41 |
2092 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 60 |
2093 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 44 |
2094 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 63 |
2095 | peripheral blood | allogeneic | myeloproliferative syndrome | hematology | 2016 | standard therapy | Poland | 52 |
2096 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Serbia | 21 |
2097 | peripheral blood | allogeneic | leukemia | hematology | 2016 | standard therapy | Lithuania | 53 |
2098 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Turkey | 4 |
2099 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2016 | standard therapy | Finland | 53 |
2100 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Italy | 52 |
2101 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Spain | 15 |
2102 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Denmark | 68 |
2103 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
2104 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Israel | 36 |
2105 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Switzerland | below 1 |
2106 | peripheral blood | allogeneic | myelofibrosis | hematology | 2016 | standard therapy | Netherlands | 66 |
2107 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Belgium | 65 |
2108 | peripheral blood | allogeneic | myelodysplastic syndrome - RCMD | hematology | 2016 | standard therapy | Czech Republic | 32 |
2109 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 59 |
2110 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | United Kingdom | 68 |
2111 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 19 |
2112 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 32 |
2113 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 55 |
2114 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 67 |
2115 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 61 |
2116 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 48 |
2117 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Netherlands | 38 |
2118 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 18 |
2119 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 46 |
2120 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 65 |
2121 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Turkey | 38 |
2122 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
2123 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Turkey | 37 |
2124 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Israel | 63 |
2125 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 55 |
2126 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 30 |
2127 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 27 |
2128 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Germany | 32 |
2129 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2016 | standard therapy | Germany | 62 |
2130 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Lithuania | 23 |
2131 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 38 |
2132 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Netherlands | 58 |
2133 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Australia | 51 |
2134 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 69 |
2135 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 62 |
2136 | peripheral blood | allogeneic | primary Immunodeficiency | hematology | 2016 | standard therapy | Russia | 5 |
2137 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 51 |
2138 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Hungary | 20 |
2139 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Hungary | 46 |
2140 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Estonia | 62 |
2141 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Spain | 58 |
2142 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2016 | standard therapy | Poland | 51 |
2143 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 72 |
2144 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 35 |
2145 | peripheral blood | allogeneic | plasma cell disorder | hematology | 2016 | standard therapy | France | 47 |
2146 | peripheral blood | allogeneic | Fanconi anaemia | hematology | 2016 | standard therapy | Estonia | 7 |
2147 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2016 | standard therapy | Germany | 63 |
2148 | peripheral blood | allogeneic | chronic myelomonocytic leukemia, minimal residual disease | hematology | 2016 | standard therapy | Poland | 50 |
2149 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 52 |
2150 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 38 |
2151 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Belgium | 56 |
2152 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Hungary | 57 |
2153 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Canada | 13 |
2154 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 24 |
2155 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 37 |
2156 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | United Kingdom | 18 |
2157 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Lithuania | 15 |
2158 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | France | 67 |
2159 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 47 |
2160 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2016 | standard therapy | Germany | 62 |
2161 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
2162 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | France | 59 |
2163 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Germany | 17 |
2164 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Ireland | 47 |
2165 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2016 | standard therapy | Germany | 67 |
2166 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Australia | 61 |
2167 | peripheral blood | allogeneic | myelofibrosis | hematology | 2016 | standard therapy | Israel | 72 |
2168 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 73 |
2169 | peripheral blood | allogeneic | aplastic anaemia | hematology | 2016 | standard therapy | United Kingdom | 23 |
2170 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Czech Republic | 59 |
2171 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 43 |
2172 | peripheral blood | allogeneic | T Cell Lymphoma/ NOS - Not otherwise specified | hematology | 2016 | standard therapy | Germany | 55 |
2173 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
2174 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 32 |
2175 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Germany | 32 |
2176 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Sweden | 58 |
2177 | peripheral blood | allogeneic | myelodysplastic syndrome - RAEB | hematology | 2016 | standard therapy | Poland | 56 |
2178 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 40 |
2179 | peripheral blood | allogeneic | refractory anemia with excess blasts | hematology | 2016 | standard therapy | United Kingdom | 62 |
2180 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Belgium | 46 |
2181 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Slovakia | 8 |
2182 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 13 |
2183 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 42 |
2184 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 64 |
2185 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 50 |
2186 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 49 |
2187 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 32 |
2188 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Czech Republic | 56 |
2189 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 29 |
2190 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 46 |
2191 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Germany | 71 |
2192 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Belgium | 30 |
2193 | peripheral blood | allogeneic | Wiskott-Aldrich syndrome | hematology | 2016 | standard therapy | Poland | 1 |
2194 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Czech Republic | 1 |
2195 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Sweden | 35 |
2196 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 28 |
2197 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 31 |
2198 | peripheral blood | allogeneic | adrenoleukodystrophy | metabolic | 2016 | standard therapy | Poland | 1 |
2199 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 18 |
2200 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2016 | standard therapy | Germany | 50 |
2201 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 54 |
2202 | peripheral blood | allogeneic | T-cell leukemia/lymphoma | hematology | 2016 | standard therapy | Canada | 31 |
2203 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 54 |
2204 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Poland | 31 |
2205 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 64 |
2206 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Columbia | 43 |
2207 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Netherlands | 69 |
2208 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
2209 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2016 | standard therapy | Sweden | 61 |
2210 | peripheral blood | allogeneic | X-linked lymphoproliferative disease | hematology | 2016 | standard therapy | Russia | 12 |
2211 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 18 |
2212 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 43 |
2213 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Netherlands | 70 |
2214 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 40 |
2215 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2016 | standard therapy | Slovakia | 52 |
2216 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Czech Republic | 45 |
2217 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Australia | 62 |
2218 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Austria | 60 |
2219 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 56 |
2220 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 58 |
2221 | adipose tissue | autologous | scar | dermatology | 2019 | clinical trial | Poland | no data |
2222 | adipose tissue | autologous | cutis laxa | dermatology | 2019 | clinical trial | Poland | no data |
2223 | adipose tissue | autologous | coxarthrosis | orthopedics | 2019 | transplantation | Poland | 34 |
2224 | adipose tissue | autologous | scar | dermatology | 2019 | clinical trial | Poland | no data |
2225 | adipose tissue | autologous | scar | dermatology | 2019 | clinical trial | Poland | no data |
2226 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2227 | adipose tissue | autologous | cutis laxa | dermatology | 2018 | clinical trial | Poland | no data |
2228 | adipose tissue | autologous | cutis laxa | dermatology | 2018 | clinical trial | Poland | no data |
2229 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2230 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2231 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2232 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2233 | adipose tissue | autologous | cutis laxa | dermatology | 2018 | clinical trial | Poland | no data |
2234 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2235 | adipose tissue | autologous | cutis laxa | dermatology | 2018 | clinical trial | Poland | no data |
2236 | adipose tissue | autologous | cutis laxa | dermatology | 2018 | clinical trial | Poland | no data |
2237 | adipose tissue | autologous | cutis laxa | dermatology | 2018 | clinical trial | Poland | no data |
2238 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2239 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2240 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2241 | adipose tissue | autologous | cutis laxa | dermatology | 2018 | clinical trial | Poland | no data |
2242 | adipose tissue | autologous | cutis laxa | dermatology | 2018 | clinical trial | Poland | no data |
2243 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2244 | adipose tissue | autologous | scar | dermatology | 2018 | clinical trial | Poland | no data |
2245 | adipose tissue | autologous | condition after injury of the left knee joint | Orthopedics | 2018 | transplantation | Poland | 33 |
2246 | adipose tissue | autologous | gonarthrosis | Orthopedics | 2018 | transplantation | Poland | 42 |
2247 | adipose tissue | autologous | gonarthrosis | Orthopedics | 2018 | transplantation | Poland | 69 |
2248 | adipose tissue | autologous | coxarthrosis | Orthopedics | 2018 | transplantation | Poland | 53 |